Other medications in the GLP-1 family approved by the FDA include Ozempic, Wegovy, Rybelsus, Saxenda, and Victozaall of which are produced by Danish manufacturer Novo Nordisk
By stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying, semaglutide helps lower blood sugar levels, which can positively impact cardiovascular health
Over time, consistently eating too little of important food groups (vegetables, fruits, proteins, dairy, etc.) can lead to gaps in nutrition
Regulatory exclusivity prevents generic and biosimilar approval regardless of patent status
These effects are particularly important to understand for patients with underlying digestive disorders like ulcerative colitis
Sleep hygiene: keep bedtime and wake-up time consistent, and limit screen time before bed